Paul Verdin, VP of consulting and analytics, and Andreas Hadjivasiliou, managing analyst at Evaluate, tell us about the company’s Orphan Drug Report 2022, which highlights activities within the ...

The story of Eli Lilly and Novo Nordisk’s GLP-1 dominance is likely to play out again in 2025 as the metabolic medicine ...

BEIJING, Dec. 18, 2024 /PRNewswire/ -- The Evaluation Report on Worldwide City Hotline Services and Governance Effectiveness (2024) was released at the 2024 Beijing Forum on Swift Response to Public ...